With thousands of legal cannabis companies operating worldwide, business owners are looking for ways to increase revenue while standing out from the crowd. What might be hard for those business owners ...

MIAMI & TORONTO--(BUSINESS WIRE)--Flora Growth Corp. (NASDAQ: FLGC) (“Flora” or the “Company”), a leading all-outdoor cultivator and manufacturer of global cannabis products and brands, is pleased to ...

Small biotechs in early development of cell therapies are often surprised by the strictness of commercial manufacturing standards. That’s the view of Luděk Sojka, PhD, CEO of contract developer and ...

MIAMI--(BUSINESS WIRE)--OrganaBio, LLC, announces initiation of GMP manufacturing operations at its new cell therapy manufacturing facility, launching a new paradigm in contract and development ...

Naprod Life Sciences renews ANVISA GMP certification for Tarapur manufacturing facility: Our Bureau, Mumbai Wednesday, ...

HanchorBio and WuXi Biologics collaborate to develop fusion proteins using the Fc-Based Designer Biologics platform, ...

Akums strengthens presence in regulated markets with EU GMP approvals for 2 Haridwar plants: Our Bureau, Bengaluru Friday, January 23, 2026, 17:45 Hrs [IST] Akums Drugs & Pharmace ...

Manufacturers are usually subjected to a diverse variety of regulations typically established by international and regional bodies. Failure to comply can result in the loss of authorization and ...

Sapio Sciences, the science-aware™ lab informatics platform, announced the Sapio GMP (Good Manufacturing Practice) LIMS for laboratories requiring unparalleled flexibility to meet manufacturing ...

Polyrizon Ltd., a biotech company developing innovative intranasal hydrogels, is preparing for a clinical trial of its PL-14 allergy blocker set for 2025. The company has partnered with Eurofins CDMO ...

Eurofins CDMO Amatsiaquitaine S.A.S., the GMP manufacturer, to support Polyrizon in future commercialization efforts Raanana, Israel, Jan. 23, 2025 (GLOBE NEWSWIRE) -- Polyrizon Ltd. (PLRZ) (the ...

WUXI, China, Sept. 17, 2025 /PRNewswire/ -- WuXi Biologics (2269.HK), a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), announced that three of its manufacturing ...